Sonelokimab (ALX0761, M1095) is a trivalent nanobody composed of monovalent camel-derived nanobodies specific for human interleukin (IL)-17A, IL-17F and human serum albumin VHH.
CAS Number:
[1414386-05-2]
* VAT and and shipping costs not included. Errors and price changes excepted